
1. nat commun. 2019 oct 4;10(1):4512. doi: 10.1038/s41467-019-12294-3.

adaptation plasmodium falciparum humans involved loss an
ape-specific erythrocyte invasion ligand.

proto wr(1), siegel sv(1), dankwa s(2), liu w(3)(4), kemp a(1), marsden s(1),
zenonos za(1), unwin s(5)(6), sharp pm(7), wright gj(1), hahn bh(3)(4),
duraisingh mt(2), rayner jc(8)(9).

author information: 
(1)malaria programme, wellcome sanger institute, wellcome genome campus,
cambridge, cb10 1sa, uk.
(2)department immunology infectious diseases, harvard t.h. chan school 
public health, boston, ma, usa.
(3)departments medicine microbiology, university pennsylvania,
philadelphia, pa, 19104, usa.
(4)department microbiology, university pennsylvania, philadelphia, pa,
19104, usa.
(5)chester zoo, chester, ch2 1lh, uk.
(6)school biosciences, university birmingham, edgbaston, b15 2tt, uk.
(7)institute evolutionary biology, university edinburgh, edinburgh, uk.
(8)malaria programme, wellcome sanger institute, wellcome genome campus,
cambridge, cb10 1sa, uk. julian.rayner@sanger.ac.uk.
(9)cambridge institute medical research, university cambridge, hills road,
cambridge, cb2 0xy, uk. julian.rayner@sanger.ac.uk.

plasmodium species frequently host-specific, little currently known
about molecular factors restricting host switching. particularly
relevant p. falciparum, known human-infective species the
laverania sub-genus, members infect african apes. show
that tested p. falciparum isolates contain inactivating mutation an
erythrocyte invasion associated gene, pfeba165, homologues are
intact ape-infective laverania species. recombinant eba165 proteins only
bind ape, human, erythrocytes, specificity due differences 
erythrocyte surface sialic acids. correction pfeba165 inactivating mutations
by genome editing yields viable parasites, associated regulation
of pfeba165 adjacent invasion ligand, suggests pfeba165
expression incompatible parasite growth human erythrocytes.
pseudogenization pfeba165 may represent key step emergence and
evolution p. falciparum.

doi: 10.1038/s41467-019-12294-3 
pmcid: pmc6778099
pmid: 31586047  [indexed medline]

